For older adults, the flu vaccine could look a little different this year.
Compared with standard flu shots, Moderna’s mFlusiva generates stronger, longer-lasting immunity and is more effective at ...
Moderna’s newly approved vaccine could allow manufacturers to respond more rapidly to changing influenza strains.
The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the ...
An mRNA-based flu (influenza) vaccine for adults 50 and over, Moderna’s mFLUSIVA, was approved by the U.S. Food and Drug Administration (FDA) on August 5. The approval offers older adults, who are at ...
The jab may be new and improved ...
The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.
The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA ...
Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 ...
6d
The new mRNA flu shot mFlusiva is more effective. Why doctors worry Long Islanders may not try it.
Although experts estimate COVID vaccines saved more than three million American lives, a survey found only 56% of Americans ...
The Food and Drug Administration has approved a new flu vaccine made with the same mRNA technology that was used for the COVID-19 shots.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results